Kodak names new execs
Eastman Kodak (Rochester, NY) has promoted Michael L. Marsh to general manager of digital output in the company's health imaging group. Marsh will replace John Farrell, who will become worldwide GM for growth services, a new role in health imaging's
Eastman Kodak (Rochester, NY) has promoted Michael L. Marsh to general manager of digital output in the company's health imaging group. Marsh will replace John Farrell, who will become worldwide GM for growth services, a new role in health imaging's global services organization. Holly Ferrell was appointed earlier as chief marketing officer and divisional vice president of health imaging.
Marsh will be responsible for the development and manufacturing of health imaging's market-leading DryView laser imagers. He is currently GM of the capture business within the company's commercial imaging group, responsible for the design, manufacture, and marketing of high-speed document scanners.
Ferrell directs worldwide product and service marketing strategies, working closely with health imaging's strategic product groups and regional organizations. She oversees product marketing, market research, training and education, and global communications.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
